European Society for Blood and Marrow Transplantation 49th Annual Meeting 2023

30 $

+ Include: 136 videos, size: 125 GB

+ Target Audience: oncologist, hematologist

Description

+ Include: 136 videos, size: 125 GB

+ Target Audience: oncologist, hematologist

+ Sample video: contact me for sample video

+ Information:

49th Annual Meeting of the EBMT

Paris Hybrid
23 – 26 April, 2023

Congress President: Mohamad Mohty
Scientific Committee Co-Chairs: Ali Bazarbachi and Patrice Chevallier
Local Nurse Chair: Thomas Jézéquel

The Annual Meeting of the EBMT is the most important annual event for research and education in the field of blood and marrow transplantation and cellular therapy in Europe. It attracts more than 6,000 participants, including international experts, scientists, physicians, nurses, statisticians, clinical research technicians, patients and processing laboratory personnel. This year’s event was held in Paris in a hybrid format offering attendees the option to attend in-person or online.

The EBMT Scientific Council, together with the local organising committee, designed an outstanding programme between Sunday, 23 April 2023 – Wednesday, 26 April 2023 that covered key issues relating to HSCT and cellular therapy research.

Most of the sessions were in-person and live-streamed through the congress platform for our virtual audience.

 

 

+ Topics:

Apr 23 How Do I… ensure the Nurse’s critical role in giving VOD patients the best chance of survival.mp4
Apr 23 Nurses Education Day 1 – Nursing challenges in 2023.mp4
Apr 23 Nurses Education Day 2 – Nursing challenges in 2023 Nurses impact on the top three.mp4
Apr 23 Nurses Education Day 3 – Nursing challenges in 2023- Understanding ..mp4
Apr 23 Nurses Education Day 4 – Nursing challenges in 2023- Future of transplant nursing.mp4
Apr 23 Opening Ceremony.mp4
Apr 23 Patient, Family and Donor Day 1 – What’s new in combatting chronic graft vs. host disease (GVHD).mp4
Apr 23 Patient, Family and Donor Day 2 – Sexual function and sexuality after haematopoietic cell transplantation- What to expect.mp4
Apr 23 Patient, Family and Donor Day 3 – Emotional experiences- Coping with Grief and Psychological Consequences of Hematopoietic Stem Cell Transplant.mp4
Apr 23 Patient, Family and Donor Day 4 – Where BMT meets CAR-T cell therapy.mp4
Apr 24 Back to basics. Understanding..mp4
Apr 24 Best practices in haplo-identical allo-HSCT.mp4
Apr 24 Cell Therapy Day 1 – Next wave of engineering.mp4
Apr 24 Cell Therapy Day 2 – Manufacturing ATMPs.mp4
Apr 24 Cell Therapy Day 3 – New application of stem cell donor.mp4
Apr 24 Cell Therapy Day 4 – Microbiome.mp4
Apr 24 Chronic Malignancies Working Party session Challenges and Controversies in Allo-HCT for Myelofibrosis.mp4
Apr 24 Data Management 1 – OMOP Introductory Session.mp4
Apr 24 Data Management 2 – CART Data Collection Initiative DM training.mp4
Apr 24 Disease management- Non-malignant disease update.mp4
Apr 24 EBMT-WMDA Transplant and Search Coordinators Day 1 – Introduction to Donor Optimisation.mp4
Apr 24 EBMT-WMDA Transplant and Search Coordinators Day 2 – Solving complicated cases- the importance of good collaboration.mp4
Apr 24 Endpoints to reach patients’ unmet needs and improve access.mp4
Apr 24 Equality, Diversity and Inclusion Session – Health inequalities- why equality, diversity and inclusion matters.mp4
Apr 24 GVHD.mp4
Apr 24 Harmonization Day 1 – Practice Harmonization and guidelines.mp4
Apr 24 Harmonization Day 2 – Practice Harmonization and guidelines committee of EBMT.mp4
Apr 24 Hot debates in ALL.mp4
Apr 24 How Do I… adapt GvHD treatment approaches- A focus on ECP – Supported through an unrestricted educational grant by Mallinckrodt.mp4
Apr 24 How Do I… avoid complications of chronic GVHD- – Supported through an unrestricted educational grant by Sanofi.mp4
Apr 24 How to Get Published-.mp4
Apr 24 Immunomodulation post-transplant.mp4
Apr 24 Infectious Diseases Working Party session.mp4
Apr 24 Joint Session- EBMT – EHA GoCART Coalition- Past, Present and Future.mp4
Apr 24 Joint Session- EBMT – HARMONY Big Data innovations for bone marrow transplant professionals.mp4
Apr 24 Joint Session- EBMT – SFH Paving the way for the future in hematology.mp4
Apr 24 Lab Technicians Day 1 – CAR cell manufacturing.mp4
Apr 24 Lab Technicians Day 2 – Gene editing technologies of T NK cells.mp4
Apr 24 Maintenance and consolidation treatment pre or post-transplant in acute leukemia .mp4
Apr 24 MRD as a surrogate marker of long-term outcome in.mp4
Apr 24 NGS in clinical practice.mp4
Apr 24 Nurses Group Opening.mp4
Apr 24 Oral Session – Adult Abstract Award Finalists.mp4
Apr 24 Oral Session – Paediatrics Abstract Award Finalists.mp4
Apr 24 Patient Advocacy Session 1 Inverting the patient involvement paradigm- defining patient led research.mp4
Apr 24 Presidential Symposium.mp4
Apr 24 Psy Day Current challenges in hematopoietic stem cell transplantation III – And after HCT.mp4
Apr 24 Psy Day- Current challenges in hematopoietic stem cell transplantation I.mp4
Apr 24 Psy Day- Current challenges in hematopoietic stem cell transplantation II.mp4
Apr 24 Psy Day- Current challenges in hematopoietic stem cell transplantation III.mp4
Apr 24 State of the art auto-transplant in (how and when).mp4
Apr 24 Trainee Day 1 – One world, different realities.mp4
Apr 24 Trainee Day 2 – What is cure to a child- Pediatric gene and cell therapy.mp4
Apr 24 Trainee Day 3 – What is transplant-related morbidity and mortality-.mp4
Apr 24 Transplant algorithm in.mp4
Apr 24 Transplant in non-malignant disorders.mp4
Apr 24 Transplant indications in rare entities.mp4
Apr 24 Vaccination after allogeneic transplantation.mp4
Apr 25 Acute Leukaemia Working Party session.mp4
Apr 25 Advances in patient care.mp4
Apr 25 Autoimmune Diseases Working Party session.mp4
Apr 25 Best Abstract Awards.mp4
Apr 25 Cell collection.mp4
Apr 25 Cellular Therapies.mp4
Apr 25 Cellular Therapy and Immunobiology Working Party session.mp4
Apr 25 EBMT next-generation session- Nursing in 2023 and beyond.mp4
Apr 25 General Assembly.mp4
Apr 25 Global Committee Session- Global views on the impact of novel therapies on hematopoietic stem cell transplantation and cell therapy.mp4
Apr 25 GVHD prophylaxis in matched sibling donor transplant.mp4
Apr 25 Hot debates in transplants for Malignant Lymphoma.mp4
Apr 25 Hot topics in transplant for AML.mp4
Apr 25 How Do I… select the right treatment at the right time for individual patients with multiple myeloma- – Supported through an unrestricted educational grant by Janssen.mp4
Apr 25 How Do I… treat MF patients with anemia- – Supported through an unrestricted educational grant by GSK.mp4
Apr 25 How Do I… treat relapsed or refractory LBCL after 1st line therapy- – Supported through an unrestricted educational grant by Bristol Myers Squibb.mp4
Apr 25 How to transplant AML patients.mp4
Apr 25 Inborn Errors Oral Session.mp4
Apr 25 Inborn Errors Working Party Session.mp4
Apr 25 Infections.mp4
Apr 25 Joint Session EBMT – KSBMT- How to Treat Steroid Refractory Chronic GVHD- Best sequence in the Era of JAK, BCR, ROCK Inhibitors.mp4
Apr 25 Joint Session EBMT – WBMT Update on The Global Data for Hematopoietic Stem Cell Transplantation.mp4
Apr 25 Joint Session EBMT-ASTCT-CIBMTR-APBMT-LABMT- How Do We Define Reduced Intensity Conditioning Regimens.mp4
Apr 25 Late complications.mp4
Apr 25 Lymphoma Working Party session.mp4
Apr 25 Management of CAR-T cell toxicities.mp4
Apr 25 Nurses Group Oral Session.mp4
Apr 25 Oral Session – Research Abstract Award Finalists.mp4
Apr 25 Paediatric Diseases Oral Session.mp4
Apr 25 Paediatric- Nutritional support.mp4
Apr 25 Paediatrics Diseases Working Party Session.mp4
Apr 25 Pharmacotherapy.mp4
Apr 25 Quality Management 1 – Center Session.mp4
Apr 25 Quality Management 2 -Challenging Standards.mp4
Apr 25 Quality Management 3 – How I manage .-.mp4
Apr 25 Refractory acute GVHD diagnosis and therapy.mp4
Apr 25 Refractory chronic GVHD diagnosis and therapy.mp4
Apr 25 Severe Aplastic Anaemia Working Party session.mp4
Apr 25 Statistical Symposium.mp4
Apr 25 Statistics Workshop.mp4
Apr 25 The EBMT Case report forum.mp4
Apr 25 Transplant Complications Working Party session – Complications of stem cell transplantation and cell therapy – what’s new.mp4
Apr 25 Transplant Complications.mp4
Apr 25 Transplant in bone marrow failures.mp4
Apr 25 Transplant in older patients.mp4
Apr 26 Cellular therapy & Closing.mp4
Apr 26 Closing Session.mp4
Apr 26 Cord Blood Transplantation.mp4
Apr 26 Gene therapy in Inborn errors.mp4
Apr 26 GOCART ongoing projects.mp4
Apr 26 Immune modulation and cellular therapy in non-hematological diseases.mp4
Apr 26 Multi-stakeholder Forum on Innovative Cellular Therapies I – Access to innovative therapies.mp4
Apr 26 Multi-stakeholder Forum on Innovative Cellular Therapies II – Hospital Exemption.mp4
Apr 26 New ways of improving patient outcome after HSCT cell therapy.mp4
Apr 26 Nurses Group & Pharmacists Joint Session.mp4
Apr 26 Oral Session 1 Acute Leukemia (I).mp4
Apr 26 Oral Session 10 Features, prevention, and management of late effects.mp4
Apr 26 Oral Session 11 Stem cell collection and manipulation.mp4
Apr 26 Oral Session 12 Aplastic anemia and bone marrow failures.mp4
Apr 26 Oral Session 13 Autoimmune diseases.mp4
Apr 26 Oral Session 14 Early Complications post HSCT- prediction and outcome.mp4
Apr 26 Oral Session 15 Conditioning regimens.mp4
Apr 26 Oral Session 16 Novel and old agents in HSCT.mp4
Apr 26 Oral Session 17 MDS and MPNs.mp4
Apr 26 Oral Session 18 Optimizing outcome after HSCT.mp4
Apr 26 Oral Session 19 Lymphoma and CLL.mp4
Apr 26 Oral Session 2 Multiple myeloma.mp4
Apr 26 Oral Session 20 Cellular therapy in lymphoma and leukemia.mp4
Apr 26 Oral Session 21 Novel approaches in HSCT.mp4
Apr 26 Oral Session 3 Heamoglobinopathies.mp4
Apr 26 Oral Session 4 Inborn errors.mp4
Apr 26 Oral Session 5 GVHD (Clinical).mp4
Apr 26 Oral Session 6 Acute Leukemia (II).mp4
Apr 26 Oral Session 7 GVHD and immunomodulation- pre-clinical.mp4
Apr 26 Oral Session 8 Infectious complications (I).mp4
Apr 26 Oral Session 9 Infectious complications (II).mp4
Apr 26 Research Committee Workshop- How to become a successful researcher.mp4
Apr 26 State of the art of auto-transplant in.mp4

Reviews

There are no reviews yet.

Be the first to review “European Society for Blood and Marrow Transplantation 49th Annual Meeting 2023”

Your email address will not be published. Required fields are marked *

+ 86 = 90
Powered by MathCaptcha